NCT01551095

Brief Summary

This research is being done to study the safety of an investigational percutaneous endoscopic gastrojejunostomy (PEGJ) tube and whether the addition of a balloon on the end of the J tube prevents it from slipping back into the stomach.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jan 2012

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 29, 2012

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 12, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
4.5 years until next milestone

Results Posted

Study results publicly available

October 12, 2016

Completed
Last Updated

March 31, 2017

Status Verified

March 1, 2017

Enrollment Period

4 months

First QC Date

February 29, 2012

Results QC Date

August 21, 2016

Last Update Submit

March 2, 2017

Conditions

Keywords

PEGJPEG-Jpercutaneous endoscopic gastrostomyfeeding tubegastroparesisacute pancreatitisstrokerespiratory failureGERDballoonself-propelled

Outcome Measures

Primary Outcomes (1)

  • Safety: Number of Participants With Adverse Events

    One week after the procedure patients were called by one of the study investigators and were asked whether or not they had Abdominal pain, Nausea or Vomiting after the procedure.

    From date of PEGJ placement up to 3 weeks

Secondary Outcomes (1)

  • Number of Participants With Retrograde Migration of PEGJ Feeding Tube Within 3 Weeks of Placement

    From date of PEGJ placement up to 3 weeks

Study Arms (1)

PEGJ

EXPERIMENTAL

Patients in this arm will receive self-propelled balloon PEGJ tube.

Device: PEGJ tube

Interventions

PEGJ tubeDEVICE

The self-propelled PEGJ feeding tube

PEGJ

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-90 years
  • need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc)
  • ability to give informed consent for the study

You may not qualify if:

  • patients with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000)
  • inability to get informed consent for the study from patients or their families
  • pregnancy (all women of child-bearing age will undergo urine pregnancy testing)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21205, United States

Location

Related Publications (1)

  • Kim KJ, Victor D, Stein E, Valeshabad AK, Saxena P, Singh VK, Lennon AM, Clarke JO, Khashab MA. A novel ballooned-tip percutaneous endoscopic gastrojejunostomy tube: a pilot study. Gastrointest Endosc. 2013 Jul;78(1):154-7. doi: 10.1016/j.gie.2013.03.005. Epub 2013 Apr 24.

MeSH Terms

Conditions

Gastroesophageal RefluxGastroparesisPancreatitisStrokeRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesStomach DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPancreatic DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesRespiration DisordersRespiratory Tract Diseases

Limitations and Caveats

Small number of patients and short follow-up

Results Point of Contact

Title
Mouen Khashab
Organization
Johns Hopkins University

Study Officials

  • Mouen Khashab, MD

    Johns Hopkins Hospital Department of Gastroenterology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine; Director of Therapeutic Endoscopy

Study Record Dates

First Submitted

February 29, 2012

First Posted

March 12, 2012

Study Start

January 1, 2012

Primary Completion

May 1, 2012

Study Completion

May 1, 2012

Last Updated

March 31, 2017

Results First Posted

October 12, 2016

Record last verified: 2017-03

Locations